<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22950074</article-id>
      <article-id pub-id-type="pmc">3427826</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2012.32.5.366</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Clinical Microbiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Quinolone-resistant <italic>Shigella flexneri</italic> Isolated in a Patient Who Travelled to India</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>You La</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nam</surname>
            <given-names>You-sun</given-names>
          </name>
          <degrees>M.S.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Gayoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Sun Young</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Yun-Tae</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Ji-Hyun</given-names>
          </name>
          <degrees>M.S.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Junyoung</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Misun</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Hee Joo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Biomedical Science, Kyung Hee University Graduate School, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Molecular Biology, Seoul Medical Science Institute/Seoul Clinical Laboratories, Seoul, Korea.</aff>
      <aff id="A5"><label>5</label>Division of Enteric Bacterial Infections, Center for Infectious Disease, National Institute of Health, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Hee Joo Lee. Department of Laboratory Medicine, School of Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-702, Korea. Tel: +82-2-958-8672, Fax: +82-2-958-8609, <email>leehejo@khmc.or.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>8</month>
        <year>2012</year>
      </pub-date>
      <volume>32</volume>
      <issue>5</issue>
      <fpage>366</fpage>
      <lpage>369</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>1</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a recent case in which ciprofloxacin-resistant Shigella flexneri was isolated from a 23-yr-old female patient with a history of travel to India. Prior to her admission to our internal medicine department, she experienced symptoms of high fever and generalized weakness from continuous watery diarrhea that developed midway during the trip. <italic>S. flexneri</italic> was isolated from the stool culture. Despite initial treatment with ciprofloxacin, the stool cultures continued to show <italic>S. flexneri</italic> growth. In the susceptibility test for antibiotics of the quinolone family, the isolate showed resistance to ciprofloxacin (minimum inhibitory concentration [MIC], 8 &#xB5;g/mL), norfloxacin (MIC, 32 &#xB5;g/mL), ofloxacin (MIC, 8 &#xB5;g/mL), nalidixic acid (MIC, 256 &#xB5;g/mL), and intermediate resistance to levofloxacin (MIC, 4 &#xB5;g/mL). In molecular studies for quinolone resistance related genes, plasmid borne-quinolone resistance genes such as <italic>qnrA</italic>, <italic>qnrB</italic>, <italic>qnrS</italic>, <italic>aac(6')-Ib-cr</italic>, <italic>qepA</italic>, and <italic>oqxAB</italic> were not detected. Two mutations were observed in gyrA (248C&#x2192;T, 259G&#x2192;A) and 1 mutation in <italic>parC</italic> (239G&#x2192;T). The molecular characteristics of the isolated <italic>S. flexneri</italic> showed that the isolate was more similar to the strains isolated from the dysentery outbreak in India than those isolated from Korea.</p>
      </abstract>
      <kwd-group>
        <kwd>Quinolone resistance</kwd>
        <kwd>
          <italic>Shigella flexneri</italic>
        </kwd>
        <kwd>Ciprofloxacin resistance</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p><italic>Shigella flexneri</italic> is an endemic organism in most developing countries and causes severe illnesses; the mortality rate of <italic>S. flexneri</italic> infections is higher than those of infections with other <italic>Shigella</italic> species [<xref ref-type="bibr" rid="B1">1</xref>]. Patients are often treated with antimicrobial agents to reduce the duration of the illness, and the treatment is known to reduce the period of <italic>Shigella</italic> excretion [<xref ref-type="bibr" rid="B2">2</xref>]. Quinolones, especially ciprofloxacin, are commonly used for the treatment of shigellosis. However, in recent years, some <italic>Shigella</italic> strains have rapidly developed resistance to antimicrobial agents [<xref ref-type="bibr" rid="B3">3</xref>]. In India, one of the endemic areas for <italic>S. flexneri</italic>, this organism is one of the predominant species isolated from cultures and shows 45.6% resistance to ciprofloxacin [<xref ref-type="bibr" rid="B4">4</xref>]. In 8 Asian countries, 12% of the <italic>S. flexneri</italic> isolates obtained from 2001 to 2004 were documented to show resistance to ciprofloxacin [<xref ref-type="bibr" rid="B5">5</xref>]. In Korea, the National Institute of Health reported 2 quinolone-resistant strains of <italic>S. flexneri</italic> among 5,938 <italic>Shigella</italic> spp. in 2008 [<xref ref-type="bibr" rid="B6">6</xref>]. Here, we present a recent case in which quinolone-resistant <italic>S. flexneri</italic> was isolated from a patient with a history of travel to India.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 23-yr-old woman had a history of high fever with a chief complaint of general weakness induced by repeated watery diarrhea. She had been in India for 10 days prior to her admission to our hospital. She experienced these symptoms midway through her trip and subsequently received fluid treatment. When she visited our hospital, diarrhea and other symptoms were absent; however, she was examined for further evaluation. Her physical examination showed that the heart rate was 64 beats/min, respiratory rate was 20 breaths/min, and the blood pressure was 110/60 mmHg. Results of laboratory investigations were as follows: hemoglobin, 11.9 g/dL; white blood cell count, 5.72&#xD7;10<sup>9</sup> cells/L (37% segmented neutrophils, 48% lymphocytes, 5% monocytes, 8% eosinophils, and 2% atypical lymphocytes); and serum sodium concentration, 141 mEq/L. Her stool occult blood cultures yielded no growth.</p>
      <p><italic>S. flexneri</italic> were abundant in the first stool culture specimen. The micro-broth dilution assay with MicroScan WalkAway 96 SI (SIEMENS, Sacramento, CA, USA) showed that the isolate was resistant to ampicillin, ampicillin/sulbactam, ciprofloxacin, and trimethoprim-sulphamethoxazole, but was susceptible to amikacin, cefepime, cefotetan, cefoxitin, cephalothin, gentamicin, imipenem, and piperacillin/tazobactam. The minimum inhibitory concentration (MIC) of ciprofloxacin was 8 &#xB5;g/mL. Initially, the patient received ciproctan (ciprofloxacin) 500 mg three times a day over 5 days. However, <italic>S. flexneri</italic> were still abundant in the follow-up stool culture, and the antibiotic-susceptibility test results also showed the same pattern from the previous results. After introduction of ceftriaxone in the treatment regimen for 5 days, <italic>S. flexneri</italic> was not isolated from the stool specimen.</p>
      <p>Quinolone susceptibility of the isolates was tested in accordance with the CLSI guidelines (<xref ref-type="table" rid="T1">Table 1</xref>). The MICs of quinolones were tested on Mueller-Hinton broth (Becton Dickinson, Baltimore, MD, USA) using the micro-broth dilution method with a 96-well cell culture plate (SPL Lifescience, Pocheon, Korea) [<xref ref-type="bibr" rid="B7">7</xref>]. <italic>E. coli</italic> ATCC 25922 was used as the control strain. The quinolone-type antibiotics tested included ciprofloxacin (Sigma Chemical Co., St. Louis, MO, USA), norfloxacin (Sigma Chemical Co.), ofloxacin (Sigma Chemical Co.), sparfloxacin (Sigma Chemical Co.), nalidixic acid (Sigma Chemical Co.), and levofloxacin (Jeil Pharmaceutical Co., Seoul, Korea).</p>
      <p>Further molecular studies, which included inspection of mutations in the quinolone target genes and the genes responsible for the expression of the efflux pump (<xref ref-type="table" rid="T2">Table 2</xref>) were performed to determine the mechanism of resistance to quinolone. Each target gene was amplified using the PCR method, while the sequencing of <italic>gyr</italic>A [<xref ref-type="bibr" rid="B8">8</xref>], <italic>gyr</italic>B [<xref ref-type="bibr" rid="B9">9</xref>], <italic>par</italic>C [<xref ref-type="bibr" rid="B8">8</xref>], <italic>parE</italic> [<xref ref-type="bibr" rid="B9">9</xref>], <italic>qnr</italic>A [<xref ref-type="bibr" rid="B6">6</xref>], <italic>qnr</italic>B [<xref ref-type="bibr" rid="B6">6</xref>], <italic>qnr</italic>S [<xref ref-type="bibr" rid="B6">6</xref>], <italic>oqx</italic>A [<xref ref-type="bibr" rid="B10">10</xref>], <italic>oqx</italic>B [<xref ref-type="bibr" rid="B10">10</xref>], and <italic>aac(6')-Ib-cr</italic> [<xref ref-type="bibr" rid="B6">6</xref>] genes was conducted by SCL (Seoul Clinical Laboratories), with a 3130XL DNA genetic analyzer (Applied Biosystems, Foster City, CA, USA). Plasmid-borne quinolone resistance genes such as <italic>qnrA</italic>, <italic>qnrB</italic>, <italic>qnrS</italic>, <italic>aac(6')-Ib-cr</italic>, <italic>qepA</italic>, and <italic>oqxAB</italic> were absent. Two mutations (248C&#x2192;T, 259G&#x2192;A) were found in <italic>gyr</italic>A and 1 mutation was found in <italic>parC</italic> (239G&#x2192;T).</p>
      <p>A laboratory test was conducted to study the expression of <italic>mdfA</italic>, <italic>tolC</italic>, and <italic>ydhE</italic>, which play a role in the encoding of the efflux pump genes, by the Korea Center for Disease Control and Prevention (KCDC) under the National Institute of Health (NIH) (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Isolates were cultured in 5 mL of Mueller-Hinton Broth (Becton Dickinson, Franklin Lakes, NJ, USA) with or without 5 &#xB5;g/mL of ciprofloxacin at 37&#x2103; for 30 min [<xref ref-type="bibr" rid="B6">6</xref>]. Total RNA was isolated using the RNeasy Mini kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's protocol. Expression of each gene was determined by real-time PCR quantification, which was based on the relative expression levels of <italic>mdfA</italic>, <italic>tolC</italic>, and <italic>ydhE</italic> when compared with the expression levels of a reference gene for 16S rRNA. The sample was quantified by PCR in a final reaction volume of 20 &#xB5;L, containing 2.5 &#xB5;L of cDNA with TaqMan One-Step RT-PCR master mix (Applied Biosystems) [<xref ref-type="bibr" rid="B6">6</xref>]. Quantification was performed on the basis of the threshold cycle (CT) value, which was determined using the LC480 software system (Roche Diagnostics, Mannheim, Germany). Relative gene expression levels were calculated as 2-&#x394;&#x394;C<sub>T</sub>, where &#x394;&#x394;C<sub>T</sub> =&#x394;C<sub>T</sub> (sample) -&#x394;C<sub>T</sub> (control), and &#x394;C<sub>T</sub> is the C<sub>T</sub> of the target gene subtracted from the C<sub>T</sub> of the housekeeping gene [<xref ref-type="bibr" rid="B11">11</xref>]. When ciprofloxacin was included in the medium, the expression levels of <italic>tolC</italic> of the <italic>S. flexneri</italic> isolate increased to 3.7 times than the expression levels in the control isolate. <italic>S. flexneri</italic> isolated from NIH was used as the control isolate, which had only one mutation in <italic>gyrA</italic> (248C&#x2192;T) with susceptibility to ciprofloxacin (MIC, 0.25 &#xB5;g/mL).</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Since 1998, cases of shigellosis caused by <italic>Shigella sonnei</italic> and <italic>S. flexneri</italic> have been steadily increasing in Korea [<xref ref-type="bibr" rid="B6">6</xref>], although cases of quinolone-resistant <italic>S. flexneri</italic> infections are still relatively rare. Several mechanisms are responsible for the development of quinolone resistance in gram-negative organisms. One of the prominent mechanisms is the mutation of the genes related to quinolone resistance. The target regions where mutations occur in the organism have been identified as topoisomerase IV (<italic>parC</italic> and <italic>parE</italic>) and DNA gyrase (<italic>gyrA</italic> and <italic>gyrB</italic>) [<xref ref-type="bibr" rid="B12">12</xref>]. Dynamic efflux of quinolone has also been observed, and effluxmodulated resistance has been reported in numerous pathogenic gram-negative bacteria [<xref ref-type="bibr" rid="B13">13</xref>]. Another mechanism depends on plasmid-mediated quinolone resistance (PMQR) determinants such as <italic>qnr</italic>, <italic>aac(6')-Ib-cr</italic>, and <italic>qepA</italic> [<xref ref-type="bibr" rid="B14">14</xref>].</p>
      <p>In the 2 previously reported quinolone-resistant strains of <italic>S. flexneri</italic> in Korea [<xref ref-type="bibr" rid="B6">6</xref>], one strain was documented to contain 3 substitutions: 1 in <italic>gyrA</italic> (Ser83&#x2192;Leu) and 2 in <italic>parC</italic> (Ser80&#x2192;Ile and Arg91&#x2192;Gln). The other strain had 4 substitutions: 2 in <italic>gyrA</italic> (Ser83&#x2192;Leu and Asp87&#x2192;Gly) and 2 in <italic>parC</italic> (Ser80&#x2192;Ile and Arg91&#x2192;Gln). Both the strains had the PMQR gene (<italic>qnrS</italic>) in common, and there was an increase in the expression levels of the efflux pump-encoding genes (<italic>mdfA</italic>, <italic>tolC</italic>, and <italic>ydhE</italic>), which were better expressed in the presence of ciprofloxacin [<xref ref-type="bibr" rid="B6">6</xref>] (<xref ref-type="table" rid="T3">Table 3</xref>). In the present case, <italic>S. flexneri</italic> showed the mutation of the genes related to quinolone resistance. Two mutations were documented in <italic>gyrA</italic>; 1 for nucleotide position 248C&#x2192;T (Ser83&#x2192;Leu) and the other for position 259G&#x2192;A (Asp87&#x2192;Asn). The change of amino acid codon 87 from aspartic acid to asparagine shows new amino acid substitution that has not been reported in the isolated strains in Korea. In parC gene, a mutation for nucleotide position 239G&#x2192;T (Ser80&#x2192;Ile) was also found. PMQR determinants were not found in the molecular analysis.</p>
      <p>According to the reports on the dysentery outbreaks in India in 2008, all isolated <italic>Shigella</italic> spp. were susceptible to ceftriaxone, a few of the quinolone-resistant strains had the <italic>aac(6')-Ib-cr</italic> gene, and none of the documented strains had <italic>qnrA</italic>, <italic>B</italic>, and <italic>S</italic> genes [<xref ref-type="bibr" rid="B15">15</xref>]. In addition, quinolone-resistant <italic>S. flexneri</italic> strains had 2 documented mutations in <italic>gyrA</italic> and 1 mutation in <italic>parC</italic>, which is similar to the corresponding findings in our case [<xref ref-type="bibr" rid="B15">15</xref>]. When the strains were treated with CCCP (carbonyl cyamide-<italic>m</italic>-chlorophenyldrazone), norfloxacin or ciprofloxacin accumulation was noted in the cells. This suggests that efflux pumps are one of the factors responsible for the development of quinolone resistance. In our case, involvement of the efflux pump in quinolone resistance was evaluated by real-time PCR analysis. The expression levels of the efflux pump-encoding gene, <italic>tolC</italic>, were higher in the presence of ciprofloxacin than in its absence.</p>
      <p>We report a case of shigellosis caused by quinolone-resistant <italic>S. flexneri</italic> , isolated from a patient who traveled to India. Although the mutation points in the <italic>gyrA</italic> and <italic>parC</italic> genes were identical to the mutation points in the strains isolated in Korea, the molecular characteristics of the isolate in our case were more similar to those of the quinolone-resistant strains isolated in India because amino acid substitutions in the strains are different and there were no PMQR genes.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haukka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Siitonen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers</article-title>
          <source>Epidemiol Infect</source>
          <year>2008</year>
          <volume>136</volume>
          <fpage>476</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="pmid">17578602</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salam</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bennish</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial therapy for shigellosis</article-title>
          <source>Rev Infect Dis</source>
          <year>1991</year>
          <volume>13</volume>
          <issue>Suppl 4</issue>
          <fpage>S332</fpage>
          <lpage>S341</lpage>
          <pub-id pub-id-type="pmid">2047659</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niyogi</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Shigellosis</article-title>
          <source>J Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>133</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">15880088</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taneja</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant <italic>Shigellae</italic> in India</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>678</fpage>
          <lpage>679</lpage>
          <pub-id pub-id-type="pmid">17122011</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuo</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Perera</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carlos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Kumarasinghe</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antimicrobial susceptibility of <italic>Shigella</italic> isolates in eight Asian countries, 2001-2004</article-title>
          <source>J Microbiol Immunol Infect</source>
          <year>2008</year>
          <volume>41</volume>
          <fpage>107</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">18473096</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Rhie</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <article-title>Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in <italic>Shigella flexneri</italic> and <italic>Shigella sonnei</italic> strains isolated in Korea</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>760</fpage>
          <lpage>765</lpage>
          <pub-id pub-id-type="pmid">18727800</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="book">
          <collab>Clinical and Laboratory Standards Institute</collab>
          <article-title>Eighteenth Informational supplement, M100-S16</article-title>
          <source>Performance standards for antimicrobial susceptibility testing</source>
          <year>2008</year>
          <publisher-loc>Wanye, PA</publisher-loc>
          <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan-Linnell</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Becnel Boyd</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steffen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zechiedrich</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms accounting for fluoroquinolone resistance in <italic>Escherichia coli</italic> clinical isolates</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>235</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">18838592</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komp Lindgren</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Mutation rate and evolution of fluoroquinolone resistance in <italic>Escherichia coli</italic> isolates from patients with urinary tract infections</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>3222</fpage>
          <lpage>3232</lpage>
          <pub-id pub-id-type="pmid">14506034</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Jacoby</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>oqxAB encoding a multidrug efflux pump in human clinical isolates of <italic>Enterobacteriaceae</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>3582</fpage>
          <lpage>3584</lpage>
          <pub-id pub-id-type="pmid">19528276</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giulietti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Overbergh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Valckx</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Decallonne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bouillon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mathieu</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>An overview of real-time quantitative PCR: applications to quantify cytokine gene expression</article-title>
          <source>Methods</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>386</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">11846608</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drlica</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>DNA gyrase, topoisomerase IV, and the 4-quinolones</article-title>
          <source>Microbiol Mol Biol Rev</source>
          <year>1997</year>
          <volume>61</volume>
          <fpage>377</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">9293187</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poole</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Efflux-mediated multiresistance in Gram-negative bacteria</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>12</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">14706082</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacoby</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cattoir</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez-Mart&#xED;nez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pascual</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>qnr</italic> Gene nomenclature</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>2297</fpage>
          <lpage>2299</lpage>
          <pub-id pub-id-type="pmid">18426894</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pazhani</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Niyogi</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Taneja</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kundu</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular characterization of multidrug-resistant <italic>Shigella</italic> species isolated from epidemic and endemic cases of shigellosis in India</article-title>
          <source>J Med Microbiol</source>
          <year>2008</year>
          <volume>57</volume>
          <fpage>856</fpage>
          <lpage>863</lpage>
          <pub-id pub-id-type="pmid">18566144</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Expression of the efflux pump genes in response to ciprofloxacin with reference to the expression levels in the control strain. Expression of <italic>tolC</italic>, <italic>mdfA</italic>, and <italic>ydhE</italic> was measured by real-time PCR in the absence and presence of ciprofloxacin. Each value represents the average of 5 culture replicates, each of which was evaluated twice. Relative gene expression levels were calculated as 2-&#x394;&#x394;C<sub>T</sub>, where &#x394;&#x394;C<sub>T</sub>=&#x394;C<sub>T</sub> (sample) - &#x394;C<sub>T</sub> (control) [<xref ref-type="bibr" rid="B11">11</xref>].</p>
        <p>CIP-: absence of ciprofloxacin; CIP+: presence of ciprofloxacin.</p>
      </caption>
      <graphic xlink:href="alm-32-366-g001"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Results of the quinolone susceptibility test by the microbroth dilution method</p>
      </caption>
      <graphic xlink:href="alm-32-366-i001"/>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>MIC level of sparfloxacin against <italic>Shigella</italic> is not mentioned in CLSI guideline.</p>
          <p>Abbreviations: MIC, minimum inhibitory concentration; R, resistance; I, Intermediate resistance.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" position="float">
      <label>Table 2</label>
      <caption>
        <p>Primers used in this study</p>
      </caption>
      <graphic xlink:href="alm-32-366-i002"/>
      <table-wrap-foot>
        <fn>
          <p>Abbreviations: FAM, 6-carboxyfluorescein; NFQ, nonfluorescent quencher.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T3" position="float">
      <label>Table 3</label>
      <caption>
        <p>Comparison between previously reported strains (strain number 1 and 2) and strain of present case (strain number 3)</p>
      </caption>
      <graphic xlink:href="alm-32-366-i003"/>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>Previously reported <italic>S. flexneri</italic> strains in Korea [<xref ref-type="bibr" rid="B6">6</xref>].</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
